Medindia LOGIN REGISTER
Medindia
Advertisement

Soon, a Magic Polypill for Heart Problems

by Rajashri on October 6, 2008 at 5:50 PM
 Soon, a Magic Polypill for Heart Problems

Scientists in London have begun testing Indian generic drug company Dr Reddy's new tablet, which can halve the risk of death due to heart attacks and stroke.

The once-a-day tablet called Red heart pill combines four different medicines - aspirin, a statin to lower cholesterol, and an ACE inhibitor and a thiazide to counter high blood pressure in one tablet, reports News Scientist.

Advertisement

The 12-week pilot trial includes seven hundred volunteers in six countries. If all goes well, the main trial with 5,000 to 7,000 volunteers will begin at the end of next year.

According to Simon Thom of Imperial College London, who is running the UK trials, the multi-drug polypill is aimed at reducing the risk of heart disease and stroke in poor and rich countries alike.
Advertisement

Thom said that there are particular groups who are not getting the required preventive therapy, both among those at modest cardiovascular risk who are not being evaluated and those at pretty serious risk who have already had a heart attack.

He said that the pill could be distributed to everyone over 55 in developing countries.

Source: ANI
RAS/SK
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Drug News

Anti-Obesity Drugs' Impact on Osteoarthritis Survival
The impact of anti-obesity drugs on survival rates among osteoarthritis patients is under scrutiny, evaluating their potential influence on mortality risks.
Can a Needle-Free Patch Transform Zika Protection?
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Prolonging Market Exclusivity of Brand-name Insulin
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
FDA Boosts Orphan Drug Designations for Myelofibrosis Treatments
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
Anti-Rheumatic Drugs May Help Prevent Thyroid Disease
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Soon, a Magic Polypill for Heart Problems Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests